Clinical Trials
2 trialsNCT00908791 2019-04-01
Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue
Dartmouth-Hitchcock Medical Center
Phase EARLY_PHASE1 Completed
NCT00951158 2015-05-12
A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors
Dartmouth-Hitchcock Medical Center
Phase 1 Terminated